$32.62
-1.26 (-3.72%)
Open$33.78
Previous Close$33.88
Day High$33.78
Day Low$32.00
52W High$36.60
52W Low$19.56
Volume—
Avg Volume353.1K
Market Cap2.44B
P/E Ratio—
EPS$-2.75
SectorPharmaceuticals
Analyst Ratings
Strong Buy
20 analysts
Price Target
-31.3% upside
Current
$32.62
$32.62
Target
$22.40
$22.40
$12.72
$22.40 avg
$29.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 601.07M | 622.81M | 541.11M |
| Net Income | 107.25M | 120.49M | 94.92M |
| Profit Margin | 17.8% | 19.4% | 17.5% |
| EBITDA | 198.86M | 206.18M | 175.68M |
| Free Cash Flow | 71.76M | 51.92M | 65.95M |
| Rev Growth | +10.0% | +14.9% | +24.5% |
| Debt/Equity | 0.21 | 0.20 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |